AEterna Zentaris (TSX:AEZS) COGS-to-Revenue : 0.45 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris COGS-to-Revenue?

AEterna Zentaris's Cost of Goods Sold for the three months ended in Dec. 2023 was C$0.07 Mil. Its Revenue for the three months ended in Dec. 2023 was C$0.16 Mil.

AEterna Zentaris's COGS to Revenue for the three months ended in Dec. 2023 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. AEterna Zentaris's Gross Margin % for the three months ended in Dec. 2023 was 54.94%.

AEterna Zentaris COGS-to-Revenue Historical Data

The historical data trend for AEterna Zentaris's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris COGS-to-Revenue Chart

AEterna Zentaris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.77

0.63

0.02

0.03

0.05

AEterna Zentaris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.02	0.01	0.06	3.75	0.45

AEterna Zentaris COGS-to-Revenue Calculation

AEterna Zentaris's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.298	/	6.035
	=	0.05

AEterna Zentaris's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.073	/	0.162
	=	0.45

AEterna Zentaris (TSX:AEZS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

AEterna Zentaris's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.073 / 0.162
	=	54.94 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

AEterna Zentaris COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

AEterna Zentaris (TSX:AEZS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

AEZS:USA ET8:Germany

Address

222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.